Insider Trading Alert - REXI, MNTX And INSY Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 18, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.00 to $575,784,180.28.

Highlighted Stocks Traded by Insiders:

Resource America (REXI) - FREE Research Report

Kozlov Hersh, who is Director at Resource America, bought 4,700 shares at $8.33 on May 18, 2015. Following this transaction, the Director owned 55,700 shares meaning that the stake was boosted by 9.22% with the 4,700-share transaction.

The shares most recently traded at $8.42, up $0.09, or 1.02% since the insider transaction. Historical insider transactions for Resource America go as follows:

  • 4-Week # shares bought: 5,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 2,080
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 2,080

The average volume for Resource America has been 41,600 shares per day over the past 30 days. Resource America has a market cap of $189.3 million and is part of the financial sector and financial services industry. Shares are down 8.85% year-to-date as of the close of trading on Monday.

Resource America, Inc. operates as an asset management company. The company, through its subsidiaries, operates in three segments: Financial Fund Management; Real Estate; and Equipment Finance. The stock currently has a dividend yield of 2.91%. The company has a P/E ratio of 29.4. Currently, there is 1 analyst who rates Resource America a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on REXI - FREE

TheStreet Quant Ratings rates Resource America as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Resource America Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Manitex International (MNTX) - FREE Research Report

Clark Ronald Michael, who is Director at Manitex International, bought 3,500 shares at $7.83 on May 18, 2015. Following this transaction, the Director owned 32,217 shares meaning that the stake was boosted by 12.19% with the 3,500-share transaction.

The shares most recently traded at $8.36, up $0.53, or 6.37% since the insider transaction. Historical insider transactions for Manitex International go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 5,000

The average volume for Manitex International has been 138,500 shares per day over the past 30 days. Manitex International has a market cap of $134.7 million and is part of the industrial goods sector and industrial industry. Shares are down 32.73% year-to-date as of the close of trading on Monday.

Manitex International, Inc. provides engineered lifting solutions. The company has a P/E ratio of 23.4. Currently, there are 5 analysts who rate Manitex International a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MNTX - FREE

TheStreet Quant Ratings rates Manitex International as a hold. Among the primary strengths of the company is its robust revenue growth -- not just in the most recent periods but in previous quarters as well. At the same time, however, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Manitex International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Insys Therapeutics (INSY) - FREE Research Report

Baker Darryl S, who is Chief Financial Officer at Insys Therapeutics, sold 10,000 shares at $59.17 on May 18, 2015. Following this transaction, the Chief Financial Officer owned 9,377 shares meaning that the stake was reduced by 51.61% with the 10,000-share transaction.

The shares most recently traded at $59.04, down $0.13, or 0.22% since the insider transaction. Historical insider transactions for Insys Therapeutics go as follows:

  • 4-Week # shares bought: 16,500
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 16,500
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 16,500
  • 24-Week # shares sold: 10,000

The average volume for Insys Therapeutics has been 436,900 shares per day over the past 30 days. Insys Therapeutics has a market cap of $2.1 billion and is part of the health care sector and drugs industry. Shares are up 41.56% year-to-date as of the close of trading on Monday.

Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company has a P/E ratio of 56.7. Currently, there are 4 analysts who rate Insys Therapeutics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on INSY - FREE

TheStreet Quant Ratings rates Insys Therapeutics as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, expanding profit margins and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Insys Therapeutics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again